Thrombectomy devices play a crucial role in the treatment of pulmonary embolisms and peripheral arterial diseases. These devices are available in various sizes and diameters, catering to specific affected areas. Surgical embolectomy, balloon embolectomy, and aspiration embolectomy are among the commonly used procedures using thrombectomy devices. Explore the advancements and applications of thrombectomy devices in the treatment of these conditions for improved patient outcomes.
According to Data Bridge Market Research, the Thrombectomy Devices Market accounted for USD 1.3 billion in 2022, would rocket up to USD 2.06 billion by 2030, and is expected to undergo a CAGR of 5.9% during the forecast period 2023 to 2030.
“Growing numbers of cardiac cases”
The increasing prevalence of cardiac conditions, such as acute ischemic stroke and deep vein thrombosis, has created a growing demand for thrombectomy devices. These devices are designed to remove blood clots from blocked arteries or veins, restoring blood flow and preventing further complications. As the need for effective and minimally invasive treatment options rises, which is driving the market growth of thrombectomy devices.
What restraints the growth of thrombectomy devices market?
“High-cost devices limit market growth”
The high cost associated with thrombectomy devices can have a negative impact on the thrombectomy device market. The high cost of these devices can limit their affordability and accessibility, especially in healthcare systems with budget constraints. This can result in lower adoption rates and slower market growth. Additionally, the high cost may deter healthcare facilities from investing in these devices, leading to limited availability and reduced utilization in clinical settings.
Segmentation: Thrombectomy Devices Market
The thrombectomy devices market is segmented on the basis of product type, application, end-user and distribution channel.
- On the basis of product type, the thrombectomy devices market is segmented into aspiration thrombectomy devices, ultrasonic thrombectomy devices, mechanical thrombectomy devices and, others.
- On the basis of application, the thrombectomy devices market is segmented into cardiovascular thrombectomy, neurovascular thrombectomy, and peripheral vascular thrombectomy.
- On the basis of end-user, the thrombectomy devices market is segmented into hospitals, trauma centres, ambulatory surgical centres and other.
- On the basis of distribution channel, the thrombectomy devices market is segmented into direct tender and retail sales.
Regional Insights: North America dominates the thrombectomy devices market
由於眾多製藥和生物技術公司的普及，加上技術進步的快速步伐和老年人口的成長，北美在血栓切除設備市場佔據主導地位。
預計亞太地區在 2023 年至 2030 年期間的成長率最高。這一增長主要受該地區老年人口增加和個人可支配收入增加等因素推動。
要了解有關該研究的更多信息，請訪問：https://www.databridgemarketresearch.com/reports/global-thrombectomy-devices-market
血栓切除設備市場的最新發展
- 2022年，強生醫療器材公司旗下Cernuous公司推出新一代球囊導管EMBOGUARD。這種創新導管專為急性缺血性中風患者的血管內手術而設計。
- 2021 年，Penumbra Inc. 進行的 CHEETAH 臨床研究展示了 Indigo System CA RX 導管的正面成果。該研究達到了其主要終點，證明接受經皮冠狀動脈介入治療 (PCI) 的高血栓負擔患者的血流恢復率、血栓清除率和心肌灌注率較高。
血栓切除設備市場的主要參與者包括：
- 美敦力（愛爾蘭）
- Inari Medical, Inc（美國）
- AngioDynamics（美國）
- 泰爾茂株式會社（日本）
- 史賽克（美國）
- Zimmer Biomet（美國）
- 波士頓科學公司（美國）
- BD（美國）
- Straub Medical AG（瑞士）
- Penumbra, Inc（美國）
- 愛德華生命科學公司（美國）
- 氬醫療。 （我們）
- Teleflex Incorporated（美國）
- phenox GmbH（德國）
- Acandis GmbH（德國）
- Merit Medical Systems（美國）
- 拜耳公司（德國）
- Getinge AB（瑞典）
- 飛利浦醫療保健（美國）
以上是報告中涉及的關鍵參與者，要了解更多血栓切除設備市場公司聯絡方式的詳盡列表，請訪問 https://www.databridgemarketresearch.com/contact
研究方法：全球血栓切除設備市場
資料收集和基準年分析是使用具有大樣本量的資料收集模組完成的。使用市場統計和相干模型來分析和估計市場數據。此外，市場佔有率分析和關鍵趨勢分析是市場報告中的主要成功因素。 DBMR 研究團隊使用的關鍵研究方法是資料三角測量，其中涉及資料探勘、資料變數對市場的影響分析以及初步（產業專家）驗證。除此之外，資料模型還包括供應商定位網格、市場時間軸分析、市場概覽和指南、公司定位網格、公司市場份額分析、測量標準、全球與區域以及供應商份額分析。如有進一步疑問，請要求分析師致電。
